...
首页> 外文期刊>American Journal of Nuclear Medicine and Molecular Imaging >Diagnosis of abnormal biliary copper excretion by positron emission tomography with targeting of 64Copper-asialofetuin complex in LEC rat model of Wilson’s disease
【24h】

Diagnosis of abnormal biliary copper excretion by positron emission tomography with targeting of 64Copper-asialofetuin complex in LEC rat model of Wilson’s disease

机译:应用正电子发射断层显像法诊断威尔逊病LEC大鼠模型中胆汁铜排泄异常并靶向64铜-亚铁血球蛋白复合物

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Identification by molecular imaging of key processes in handling of transition state metals, such as copper (Cu), will be of considerable clinical value. For instance, the ability to diagnose Wilson’s disease with molecular imaging by identifying copper excretion in an ATP7B-dependent manner will be very significant. To develop highly effective diagnostic approaches, we hypothesized that targeting of radiocopper via the asialoglycoprotein receptor will be appropriate for positron emission tomography, and examined this approach in a rat model of Wilson’s disease. After complexing sup64/supCu to asialofetuin we studied handling of this complex compared with sup64/supCu in healthy LEA rats and diseased homozygous LEC rats lacking ATP7B and exhibiting hepatic copper toxicosis. We analyzed radiotracer clearance from blood, organ uptake, and biliary excretion, including sixty minute dynamic positron emission tomography recordings. In LEA rats, sup64/supCu-asialofetuin was better cleared from blood followed by liver uptake and greater biliary excretion than sup64/supCu. In LEC rats, sup64/supCu-asialofetuin activity cleared even more rapidly from blood followed by greater uptake in liver, but neither sup64/supCu-asialofetuin nor sup64/supCu appeared in bile. Image analysis demonstrated rapid visualization of liver after sup64/supCu-asialofetuin administration followed by decreased liver activity in LEA rats while liver activity progressively increased in LEC rats. Image analysis resolved this difference in hepatic activity within one hour. We concluded that sup64/supCu-asialofetuin complex was successfully targeted to the liver and radiocopper was then excreted into bile in an ATP7B-dependent manner. Therefore, hepatic targeting of radiocopper will be appropriate for improving molecular diagnosis and for developing drug/cell/gene therapies in Wilson’s disease.
机译:通过分子成像对处理过渡态金属(例如铜(Cu))中的关键过程进行鉴定将具有重要的临床价值。例如,通过以ATP7B依赖性方式鉴定铜排泄物,利用分子成像技术诊断威尔逊氏病的能力将非常重要。为了开发高效的诊断方法,我们假设通过去唾液酸糖蛋白受体靶向放射性铜将适用于正电子发射断层扫描,并在威尔逊病大鼠模型中检查了该方法。在将 64 Cu与去唾液酸铁蛋白复合后,我们研究了该复合物与 64 Cu在健康的LEA大鼠和患病的纯合性LEC大鼠中缺乏ATP7B并表现出肝铜中毒的作用。我们分析了放射性示踪剂从血液,器官摄取和胆汁排泄的清除率,包括60分钟动态正电子发射断层扫描记录。在LEA大鼠中,与 64 Cu相比, 64 Cu-asialofetuin的血液清除效果更好,随后可被肝脏吸收,并且胆汁排泄量更大。在LEC大鼠中, 64 Cu-asialofetuin活性从血液中清除的速度甚至更快,随后被肝脏吸收更多,但是 64 Cu-asialofetuin和 64 铜出现在胆汁中。图像分析显示,给予 64 Cu-asialofetuin后,肝脏快速可视化,随后LEA大鼠肝脏活性降低,而LEC大鼠肝脏活性逐渐升高。图像分析在一小时内解决了肝脏活动的这种差异。我们得出结论, 64 Cu-asialofetuin复合物已成功靶向肝,然后放射性铜以ATP7B依赖性方式排泄到胆汁中。因此,放射性铜的肝靶向将适合改善威尔逊氏病的分子诊断和开发药物/细胞/基因疗法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号